- RecruitingPHASE2
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
This study is testing a new medicine, CDR132L, for people with heart failure. It aims to see how the medicine affects the heart's structure and function. Some people will get the new medicine, others a dummy pill, to compare the results over about 60 weeks.
For: Heart FailureAustralia · Czechia · Germany - RecruitingPHASE2
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
This study investigates CDR132L, a new potential medicine, for people with heart failure. It compares different doses against a dummy treatment (placebo) to see how it affects heart structure and function. Participants will be in the study for about 60 weeks.
For: Heart FailureUnited States · Canada · Germany